Simplex Trading’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$495K Buy
+54,917
New +$867K ﹤0.01% 3277
2025
Q4
Sell
-52,851
Closed -$891K 8367
2025
Q3
$774K Buy
+52,851
New +$906K ﹤0.01% 3312
2024
Q1
Sell
-14,714
Closed -$80.4K 8724
2023
Q4
$66K Buy
14,714
+13,021
+769% +$48.2K ﹤0.01% 5807
2023
Q3
$6K Buy
+1,693
New +$6.52K ﹤0.01% 7495
2022
Q3
Sell
-9,070
Closed -$21.8K 9788
2022
Q2
$17K Buy
9,070
+957
+12% +$1.88K ﹤0.01% 7751
2022
Q1
$14K Buy
8,113
+6,696
+473% +$10.4K ﹤0.01% 8565
2021
Q4
$1K Sell
1,417
-181,779
-99% -$239K ﹤0.01% 10127
2021
Q3
$291K Hold
183,196
﹤0.01% 4948
2021
Q2
$293K Buy
183,196
+12,832
+8% +$22.6K ﹤0.01% 5018
2021
Q1
$299K Buy
+170,364
New +$390K ﹤0.01% 4146
2020
Q4
Sell
-414
Closed -$870 8245
2020
Q3
$0 Sell
414
-113,949
-100% -$312K ﹤0.01% 7688
2020
Q2
$335K Buy
114,363
+87,615
+328% +$252K ﹤0.01% 3395
2020
Q1
$77K Buy
26,748
+21,746
+435% +$75.2K ﹤0.01% 4650
2019
Q4
$20K Buy
+5,002
New +$21.8K ﹤0.01% 5936
2019
Q1
Sell
-284
Closed -$1K 7042
2018
Q4
$0 Sell
284
-5,379
-95% -$26.6K ﹤0.01% 6895
2018
Q3
$35K Buy
+5,663
New +$32.6K ﹤0.01% 5496

Other funds holding ADMA

Simplex Trading's ADMA Position: Q1 2026 in Review

Simplex Trading opened a new position in ADMA Biologics (ADMA) in Q1 2026: 54,917 shares worth $495K. The stake represents ﹤0.01% of the portfolio and ranks #3277 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ADMA as recently as Q3 2025.

Simplex Trading first reported a position in ADMA in Q3 2018 and has held it in 16 quarters since. The position peaked at $774K in Q3 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Simplex Trading held 54,917 shares of ADMA Biologics worth $495K as of Q1 2026.
  • ADMA Biologics was a new Simplex Trading position in Q1 2026.
  • ADMA Biologics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3277 holding.
  • Simplex Trading first reported a position in ADMA Biologics in Q3 2018 and has held it in 16 quarters since.
  • Simplex Trading's ADMA Biologics position peaked at $774K in Q3 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.